1,215
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

TDP-43 and ubiquitinated cytoplasmic aggregates in sporadic ALS are low frequency and widely distributed in the lower motor neuron columns independent of disease spread

, , , , &
Pages 321-327 | Received 26 Oct 2009, Accepted 04 Jan 2010, Published online: 12 Mar 2010

References

  • Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM. Ubiquitin deposits in anterior horn cells in motor neuron disease. Neuroscience Letters. 1988; 93:197–203.
  • Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
  • Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, . TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications. 2006;351:602–11.
  • Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, . Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61:427–34.
  • Robertson J, Sanelli T, Xiao S, Yang W, Horne P, Hammond R, . Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci Lett. 2007; 420:128–32.
  • Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, . TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668–72.
  • Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, van de Velde C, . TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572–4.
  • van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, . TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409–16.
  • Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, . Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Nat Acad Sciences. 2009;106:7606–12.
  • Giordana MT, Piccinini M, Grifoni S, de Marco G, Vercellino M, Magistrello M, . TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathology. 2009. doi:10.1111/j.1750-3639.2009.00284
  • Wegorzewskaa I, Bell I, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA. 2009;106:18809–14.
  • Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post mortem. Neurology. 2007;68:1576–82.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Olszewski J, Baxter D. Cytoarchitecture of the Human Brain Stem, 2nd. Basel (Switzerland); S. Karger: 1982. Plates VIII–XX, 26–38 and pp 62–3.
  • Sanelli T, Xiao S, Horne P, Bilbao J, Zinman L, Robertson J. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2007;66:1147–53.
  • Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, Takahashi H, . Maturation process of TDP-43 positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008;116:193–203.
  • Sathasivam S, Ince PG, Shaw PJ. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol. 2001;27:257–74.
  • Guégan C, Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest. 2003;111:153–61.
  • Sumi H, Kato S, Mochimaru Y, Fujimura H, Etoh M, Sakoda S. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2008;68:37–47.